Beijing Sun-Novo Pharmaceutical Research (688621.SH) co-builds a joint laboratory with Peking University Medical School.
Sunshine Pharma (688621.SH) announced that, in order to implement the national strategy for scientific and technological development, enhance independent innovation capabilities and national core competitiveness, and promote the quality and efficiency of innovative research and development work, the company is collaborating with the Beijing University Medical Department to jointly establish the "Peking University Medical-Sunshine Pharma Innovation Drug Joint Laboratory". Both parties will focus on cutting-edge areas such as cell therapy, gene therapy, and develop clinical candidate drugs as the core goal, fully leveraging their respective strengths to jointly promote the high-quality development of the company in the field of innovative drug research and development.
Beijing Sun-Novo Pharmaceutical Research (688621.SH) announced that in order to implement the national science and technology development policy, enhance independent innovation capabilities and national core competitiveness, promote the quality and efficiency of innovation research and development work, the company has collaborated with Peking University School of Medicine to jointly establish the "Peking University Medicine-Beijing Sun-Novo Pharmaceutical Research Innovative Drug Joint Laboratory." The two parties will focus on frontier areas such as cell therapy and gene therapy, with the core goal of developing clinical candidate drugs, fully leveraging their respective strengths, and jointly promoting the high-quality development of the company in the field of innovative drug research and development.
Related Articles

Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Northeast: Music ecosystem giant NETEASE MUSIC (09899) benefits from rapid industry growth.

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


